This HCPLive Five features advancements in asthma, immunology, and allergy that were presented at the ACAAI 2025 meeting in Orlando.
Princess Ogbogu, MD
Advertisement
Princess Ogbogu, MD, from the University of Hospitals Rainbow Babies & Children’s Hospital
Articles by Princess Ogbogu, MD
In a phase 3 NATRON trial presented at ACAAI 2025, Ogbogu discussed how benralizumab reduced flare in patients with hypereosinophilic syndrome.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Interstitial Lung Abnormalities: Recognition, Risk Stratification, and When to Act
2
Q&A: Intensive LDL Lowering and Cardiovascular Prevention Strategies, With Lawrence Leiter, MD
3
Management Strategies for Hypercortisolism
4
Integrating Hypercortisolism Screening into Clinical Practice
5